Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling

Molecular and Cellular Biology

Volumn 23, Issue 21, 2003, Pages 7875-7886

  Agazie, Yehenew M ^a   Hayman, Michael J ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MUTANT PROTEIN; PHENYLALANINE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; RAS PROTEIN; SRC HOMOLOGY 2 CONTAINING PHOSPHOTYROSINE PHOSPHATASE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CATALYST; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INACTIVATION; ENZYME SUBSTRATE; GENE MUTATION; HALF LIFE TIME; MITOGENESIS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; CELL LINE; CELL MEMBRANE; ENZYME ACTIVATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN TRANSPORT; PROTEIN-TYROSINE-PHOSPHATASE; RAS GTPASE-ACTIVATING PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TYROSINE;

ANIMALIA;

EID: 0142059890     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.21.7875-7886.2003     Document Type: Article

References (59)

1. Agazie, Y. M., and M. J. Hayman. Oncogene, in press.
2. Agazie, Y. M., and M. J. Hayman. 2003. Development of an efficient "substrate-trapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates. J. Biol. Chem. 278:13952-13958.
3. Bardelli, A., P. Longati, D. Gramaglia, M. C. Stella, and P. M. Comoglio. 1997. Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potential. Oncogene 15:3103-3111.
4. Bennett, A. M., S. F. Hausdorff, A. M. O'Reilly, R. M. Freeman, and B. G. Neel. 1996. Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression. Mol. Cell. Biol. 16:1189-1202.
5. Carlberg, K., and L. R. Rohrschneider. 1997. Characterization of a novel tyrosine phosphorylated 100-kDa protein that binds to SHP-2 and phosphatidylinositol 3′-kinase in myeloid cells. J. Biol. Chem. 272:15943-15950.
6. Chardin, P., J. H. Camonis, N. W. Gale, L. van Aelst, J. Schlessinger, M. H. Wigler, and D. Bar-Sagi. 1993. Hum. Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 260:1338-1343.
7. Chatterjee-Kishore, M., F. van den Akker, and G. R. Stark. 2000. Association of STATs with relatives and friends. Trends Cell Biol. 10:106-111.
8. Cleghon, V., P. Feldmann, C. Ghiglione, T. D. Copeland, N. Perrimon, D. A. Hughes, and D. K. Morrison. 1998. Opposing actions of CSW and RasGAP modulate the strength of Torso RTK signaling in the Drosophila terminal pathway. Mol. Cell 2:719-727.
9. Cunnick, J. M., J. F. Dorsey, T. Munoz-Antonia, L. Mei, and J. Wu. 2000. Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor. J. Biol. Chem. 275:13842-13848.
10. Deb, T. B., L. Wong, D. S. Salomon, G. Zhou, J. E. Dixon, J. S. Gutkind, S. A. Thompson, and G. R. Johnson. 1998. A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors. A specific role for SHP-2 in map, but not c-Jun amino-terminal kinase activation. J. Biol. Chem. 273:16643-16646.
11. DeMali, K. A., E. Balciunaite, and A. Kazlauskas. 1999. Integrins enhance platelet-derived growth factor (PDGF)-dependent responses by altering the signal relay enzymes that are recruited to the PDGF beta receptor. J. Biol. Chem. 274:19551-19558.
12. Di Fiore, P. P., J. H. Pierce, T. P. Fleming, R. Hazan, A. Ullrich, C. R. King, J. Schlessinger, and S. A. Aaronson. 1987. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51:1063-1070.
13. Dionne, C. A., M. Jaye, and J. Schlessinger. 1991. Structural diversity and binding of FGF receptors. Ann. N. Y. Acad. Sci. 638:161-166.
14. Emlet, D. R., D. K. Moscatello, L. B. Ludlow, and A. J. Wong. 1997. Subsets of epidermal growth factor receptors during activation and endocytosis. J. Biol. Chem. 272:4079-4086.
15. Feng, G. S., C. C. Hui, and T. Pawson. 1993. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science 259:1607-1611.
16. Feng, G. S., and T. Pawson. 1994. Phosphotyrosine phosphatases with SH2 domains: regulators of signal transduction. Trends Genet. 10:54-58.
17. Frearson, J. A., and D. R. Alexander. 1998. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells. J. Exp. Med. 187:1417-1426.
18. Hadari, Y. R., H. Kouhara, I. Lax, and J. Schlessinger. 1998. Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation. Mol. Cell. Biol. 18:3966-3973.
19. Hakak, Y., Y. S. Hsu, and G. S. Martin. 2000. Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt. Oncogene 19:3164-3171.
20. Honegger, A. M., A. Schmidt, A. Ullrich, and J. Schlessinger. 1990. Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells. Mol. Cell. Biol, 10:4035-4044.
21. Johnson, D. E., and L. T. Williams. 1993. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60:1-41.
22. Kazlauskas, A., D. L. Durden, and J. A. Cooper. 1991. Functions of the major tyrosine phosphorylation site of the PDGF receptor beta subunit. Cell Regul. 2:413-425.
23. Keyse, S. M. 2000. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12:186-192.
24. Klinghoffer, R. A., and A. Kazlauskas. 1995. Identification of a putative Syp substrate, the PDGF beta receptor. J. Biol. Chem. 270:22208-22217.
25. Kuhne, M. R., T. Pawson, G. E. Lienhard, and G. S. Feng. 1993. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J. Biol. Chem. 268:11479-11481.
26. Lechleider, R. J., S. Sugimoto, A. M. Bennett, A. S. Kashishian, J. A. Cooper, S. E. Shoelson, C. T. Walsh, and B. G. Neel. 1993. Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. J. Biol. Chem. 268:21478-21481.
27. Margolis, B., N. Li, A. Koch, M. Mohammadi, D. R. Hurwitz, A. Zilberstein, A. Ullrich, T. Pawson, and J. Schlessinger. 1990. The tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-gamma. EMBO J. 9:4375-4380.
28. Maroun, C. R., M. A. Naujokas, M. Holgado-Madruga, A. J. Wong, and M. Park. 2000. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the Met receptor tyrosine kinase. Mol. Cell. Biol. 20:8513-8525.
29. Massoglia, S., A. Gray, T. J. Dull, S. Munemitsu, H. J. Kun, J. Schlessinger, and A. Ullrich. 1990. Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation. Mol. Cell. Biol. 10: 3048-3055.
30. Melillo, R. M., M. Santoro, S. H. Ong, M. Billaud, A. Fusco, Y. R. Hadari, J. Schlessinger, and I. Lax. 2001. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol. Cell. Biol. 21:4177-4187.
31. Milarski, K. L., and A. R. Saltiel. 1994. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol. Chem. 269:21239-21243.
32. Neel, B. G., and N. K. Tonks. 1997. Protein tyrosine phosphatases in signal transduction. Curr. Opin. Cell Biol. 9:193-204.
33. Noguchi, T., T. Matozaki, K. Horita, Y. Fujioka, and M. Kasuga. 1994. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol. Cell. Biol. 14:6674-6682.
34. Ong, S. H., G. R. Guy, Y. R. Hadari, S. Laks, N. Gotoh, J. Schlessinger, and I. Lax. 2000. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol. Cell. Biol. 20:979-989.
35. O'Reilly, A. M., S. Pluskey, S. E. Shoelson, and B. G. Neel. 2000. Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps. Mol. Cell. Biol. 20:299-311.
36. Park, C. Y., and M. J. Hayman. 1999. The tyrosines in the bidentate motif of the env-sea oncoprotein are essential for cell transformation and are binding sites for Grb2 and the tyrosine phosphatase SHP-2. J. Biol. Chem. 274:7583-7590.
37. Park, M., M. Dean, K. Kaul, M. J. Braun, M. A. Gonda, and G. Vande Woude. 1987. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA 84:6379-6383.
38. Pawson, T., and G. D. Gish. 1992. SH2 and SH3 domains: from structure to function. Cell 71:359-362.
39. Saxton, T. M., B. G. Ciruna, D. Holmyard, S. Kulkarni, K. Harpal, J. Rossant, and T. Pawson. 2000. The SH2 tyrosine phosphatase shp2 is required for mammalian limb development. Nat. Genet. 24:420-423.
40. Saxton, T. M., M. Henkemeyer, S. Gasca, R. Shen, D. J. Rossi, F. Shalaby, G. S. Feng, and T. Pawson. 1997. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16:2352-2364.
41. Schaeper, U., N. H. Gehring, K. P. Fuchs, M. Sachs, B. Kempkes, and W. Birchmeier. 2000. Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J. Cell Biol. 149:1419-1432.
42. Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103: 211-225.
43. Schlessinger, J., M. Mohammadi, B. Margolis, and A. Ullrich. 1992. Role of SH2-containing proteins in cellular signaling by receptor tyrosine kinases. Cold Spring Harbor Symp. Quant. Biol. 57:67-74.
44. Shi, Z. Q., D. H. Yu, M. Park, M. Marshall, and G. S. Feng. 2000. Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity. Mol. Cell. Biol. 20:1526-1536.
45. Sorkin, A., K. Helin, C. M. Waters, G. Carpenter, and L. Beguinot. 1992. Multiple autophosphorylation sites of the epidermal growth factor receptor are essential for receptor kinase activity and internalization. Contrasting significance of tyrosine 992 in the native and truncated receptors. J. Biol. Chem. 267:8672-8678.
46. Stein-Gerlach, M., A. Kharitonenkov, W. Vogel, S. Ali, and A. Ullrich. 1995. Protein-tyrosine phosphatase 1D modulates its own state of tyrosine phosphorylation. J. Biol. Chem. 270:24635-24637.
47. Sugimoto, S., R. J. Lechleider, S. E. Shoelson, B. G. Neel, and C. T. Walsh. 1993. Expression, purification, and characterization of SH2-containing protein tyrosine phosphatase, SH-PTP2. J. Biol. Chem. 268:22771-22776.
48. Tang, T. L., R. M. Freeman, Jr., A. M. O'Reilly, B. G. Neel, and S. Y. Sokol. 1995. The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. Cell 80: 473-483.
49. Tapley, P., A. Kazlauskas, J. A. Cooper, and L. R. Rohrschneider. 1990. Macrophage colony-stimulating factor-induced tyrosine phosphorylation of c-fms proteins expressed in FDC-P1 and BALB/c 3T3 cells. Mol. Cell. Biol. 10:2528-2538.
50. Tartaglia, M., C. M. Niemeyer, A. Fragale, X. Song, J. Buechner, A. Jung, K. Hahlen, H. Hasle, J. D. Licht, and B. D. Gelb. 2003. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat. Genet. 34:148-150.
51. Taylor, S. J., and D. Shalloway. 1996. Cell cycle-dependent activation of Ras. Curr. Biol. 6:1621-1627.
52. Tomic, S., U. Greiser, R. Lammers, A. Kharitonenkov, E. Imyanitov, A. Ullrich, and F. D. Bohmer. 1995. Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C. J. Biol. Chem. 270:21277-21284.
53. Tonks, N. K., and B. G. Neel. 2001. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr. Opin. Cell Biol. 13:182-195.
54. Tonks, N. K., and B. G. Neel. 1996. From form to function: signaling by protein tyrosine phosphatases. Cell 87:365-368.
55. Tulasne, D., R. Paumelle, K. M. Weidner, B. Vandenbunder, and V. Fafeur. 1999. The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. Mol. Biol. Cell 10:551-565.
56. Ueki, N., and M. J. Hayman. 2003. Signal-dependent N-CoR requirement for repression by the Ski oncoprotein. J. Biol. Chem. 278:24858-24864.
57. Ullrich, A., L. Coussens, J. S. Hayflick T. J. Dull, A. Gray, A. W. Tam, J. Lee, Y. Yarden, T. A. Libermann, J. Schlessinger, et al. 1984. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418-425.
58. Watanabe, S., and K. Arai. 1996. Roles of the JAK-STAT system in signal transduction via cytokine receptors. Curr. Opin. Genet. Dev. 6:587-596.
59. Zhang, Z. Y., Y. Wang, L. Wu, E. B. Fauman, J. A. Stuckey, H. L. Schubert, M. A. Saper, and J. E. Dixon. 1994. The Cys(X)5Arg catalytic motif in phosphoester hydrolysis. Biochemistry 33:15266-15270.